HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY
Clinical trials for HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could stop swelling attacks in their tracks
Symptom relief CompletedThis study tested an oral medication called deucrictibant for treating sudden swelling attacks in people with hereditary angioedema (HAE), a rare genetic condition. The trial involved 134 adolescents and adults aged 12 to 75 who took either the drug or a placebo at the start of a…
Matched conditions: HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated May 26, 2026 09:03 UTC
-
New pill could quickly ease swelling attacks in rare genetic condition
Symptom relief CompletedThis study tested an oral medication called deucrictibant for treating sudden swelling attacks in people with hereditary angioedema (HAE) types I and II. 74 adults received either one of three doses of the drug or a placebo during an attack. The main goal was to see if the drug r…
Matched conditions: HEREDITARY ANGIOEDEMA WITH C1 ESTERASE INHIBITOR DEFICIENCY
Phase: PHASE2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated May 26, 2026 09:02 UTC